Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.
Testosterone therapy has its benefits and risks. Here’s what experts have revealed about the symptoms, causes of low testosterone, and how to make informed treatment decisions.